000154697 001__ 154697
000154697 005__ 20240229123109.0
000154697 0247_ $$2doi$$a10.21873/invivo.11945
000154697 0247_ $$2pmid$$apmid:32354962
000154697 0247_ $$2ISSN$$a0258-851X
000154697 0247_ $$2ISSN$$a1791-7549
000154697 037__ $$aDKFZ-2020-00955
000154697 041__ $$aeng
000154697 082__ $$a610
000154697 1001_ $$0P:(DE-He78)ca89260a6f950d2149ad4aa50732aa2c$$aZwicker, Felix$$b0$$eFirst author$$udkfz
000154697 245__ $$aLack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer.
000154697 260__ $$aKapandriti, Attiki$$bIIAR$$c2020
000154697 3367_ $$2DRIVER$$aarticle
000154697 3367_ $$2DataCite$$aOutput Types/Journal article
000154697 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1635948970_5222
000154697 3367_ $$2BibTeX$$aARTICLE
000154697 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154697 3367_ $$00$$2EndNote$$aJournal Article
000154697 500__ $$a#EA:E055#
000154697 520__ $$aIn percutaneous radiotherapy dose-distribution and volumetric-load of normal tissue varies in different radiation-techniques. Haematotoxicity may lead to deficiencies of the immune and blood system or to secondary malignancies. Therefore, regular blood-counts are carried out during fractionated radiotherapy. The aim was to investigate patient haemogram courses during radiotherapy of localised prostate-cancer treated with different radiation-techniques (n=3).In this prospective study, blood count changes were examined during fractionated radiotherapy (3D-conformal-RT/step-and-shoot-IMRT/helical-IMRT) on the prostate-region in localised prostate-cancer cases (n=50).The whole patient group displayed a small but significant reduction in leukocytes. This reduction was higher in the two IMRT groups compared to the 3D-group but without any case of leukopenia. Haemoglobin- or thrombocyte-levels did not significantly change.Regardless of the delivery mode used, localised fractionated irradiation of prostate region did not cause any clinically relevant haemogram changes in this study. These findings question the necessity of regular blood counts during fractionated radiotherapy of the prostate region for patients without any risk factors.
000154697 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000154697 588__ $$aDataset connected to CrossRef, PubMed,
000154697 7001_ $$aSwartman, Benedict$$b1
000154697 7001_ $$0P:(DE-He78)3291aaac20f3d603d96744c1f0890028$$aHuber, Peter E$$b2$$udkfz
000154697 7001_ $$aHerfarth, Klaus$$b3
000154697 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b4$$udkfz
000154697 7001_ $$aHauswald, Henrik$$b5
000154697 773__ $$0PERI:(DE-600)2492569-X$$a10.21873/invivo.11945$$gVol. 34, no. 3, p. 1555 - 1563$$n3$$p1555 - 1563$$tIn vivo$$v34$$x1791-7549$$y2020
000154697 909CO $$ooai:inrepo02.dkfz.de:154697$$pVDB
000154697 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ca89260a6f950d2149ad4aa50732aa2c$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000154697 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3291aaac20f3d603d96744c1f0890028$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000154697 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000154697 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000154697 9141_ $$y2020
000154697 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154697 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154697 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000154697 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bIN VIVO : 2017
000154697 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154697 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154697 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154697 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154697 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000154697 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154697 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Translationale Radioonkologie$$x0
000154697 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lE050 KKE Strahlentherapie$$x1
000154697 9200_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Translationale Radioonkologie$$x0
000154697 980__ $$ajournal
000154697 980__ $$aVDB
000154697 980__ $$aI:(DE-He78)E055-20160331
000154697 980__ $$aI:(DE-He78)E050-20160331
000154697 980__ $$aUNRESTRICTED